When will Inrebic® be available for prescription?

It is scheduled to be available for prescription at medical institutions from the launch date of June 1, 2026.

What is the indication for Inrebic®?

It is used for the treatment of myelofibrosis.

How should it be administered?

Typically, adults are administered 400 mg of fedratinib once daily orally (dosage may be reduced based on patient status).

AI News NQ Analysis

[Recordati] Announcement regarding the drug price listing and launch date of myelofibrosis treatment 'Inrebic®'

NQ Score 43/100

N1 Content Completeness 5

Key facts

[Recordati] Announcement regarding the drug price listing and launch date of myelofibrosis treatment 'Inrebic®'
Recordati Rare Diseases Japan has announced the drug price listing of its myelofibrosis treatment 'Inrebic®' (fedratinib hydrochloride hydrate) and its scheduled market launch on June 1, 2026.
Source: PR TIMES
Date: Thu May 21 2026 01:00:01 GMT+0900 (Japan Standard Time)

Direct answer

Recordati Rare Diseases Japan has announced the drug price listing of its myelofibrosis treatment 'Inrebic®' (fedratinib hydrochloride hydrate) and its scheduled market launch on June 1, 2026.

Citation: [Recordati] Announcement regarding the drug price listing and launch date of myelofibrosis treatment 'Inrebic®' (Thu May 21 2026 01:00:01 GMT+0900 (Japan Standard Time)), PR TIMES
Source: PR TIMES
Date: Thu May 21 2026 01:00:01 GMT+0900 (Japan Standard Time)

AI Summary (NQ-processed)

Recordati Rare Diseases Japan has announced the drug price listing of its myelofibrosis treatment 'Inrebic®' (fedratinib hydrochloride hydrate) and its scheduled market launch on June 1, 2026.

AI Analysis

Frequently Asked Questions

Q: When will Inrebic® be available for prescription?: A: It is scheduled to be available for prescription at medical institutions from the launch date of June 1, 2026.
Q: What is the indication for Inrebic®?: A: It is used for the treatment of myelofibrosis.
Q: How should it be administered?: A: Typically, adults are administered 400 mg of fedratinib once daily orally (dosage may be reduced based on patient status).